Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Current Leases (2020 - 2025)

Historic Current Leases for Altimmune (ALT) over the last 6 years, with Q3 2025 value amounting to $247000.0.

  • Altimmune's Current Leases fell 2108.63% to $247000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $247000.0, marking a year-over-year decrease of 2108.63%. This contributed to the annual value of $279000.0 for FY2024, which is 4375.0% down from last year.
  • As of Q3 2025, Altimmune's Current Leases stood at $247000.0, which was down 2108.63% from $239000.0 recorded in Q2 2025.
  • In the past 5 years, Altimmune's Current Leases ranged from a high of $508000.0 in Q1 2024 and a low of $239000.0 during Q2 2025
  • Its 5-year average for Current Leases is $390687.5, with a median of $426000.0 in 2022.
  • As far as peak fluctuations go, Altimmune's Current Leases surged by 1521.77% in 2021, and later crashed by 5177.17% in 2025.
  • Over the past 5 years, Altimmune's Current Leases (Quarter) stood at $411000.0 in 2021, then rose by 9.98% to $452000.0 in 2022, then increased by 9.73% to $496000.0 in 2023, then plummeted by 43.75% to $279000.0 in 2024, then dropped by 11.47% to $247000.0 in 2025.
  • Its last three reported values are $247000.0 in Q3 2025, $239000.0 for Q2 2025, and $245000.0 during Q1 2025.